Drug Interactions Flashcards
6 cards from real Pharmacy practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 6 Drug Interactions flashcards as text
Rifampin is a potent inducer of CYP450 enzymes. When a patient on oral contraceptives starts rifampin, you should warn them about:
Answer: Decreased contraceptive efficacy and risk of unintended pregnancy
Rifampin induces CYP3A4, accelerating metabolism of estrogen/progestin in oral contraceptives, reducing their plasma levels and effectiveness.
The combination of sildenafil and nitrates is contraindicated because it can cause:
Answer: Severe hypotension
Both nitrates and PDE5 inhibitors (sildenafil) decrease cGMP degradation/increase nitric oxide, causing additive vasodilation and potentially fatal hypotension.
Which drug interaction occurs when phenytoin decreases the effect of doxycycline by increasing its metabolism?
Answer: CYP enzyme induction
Phenytoin is a CYP enzyme inducer; it increases the metabolism of doxycycline, reducing its half-life and therapeutic plasma levels.
Lithium toxicity risk increases when a patient starts a thiazide diuretic because:
Answer: Thiazides cause sodium depletion, leading to compensatory lithium reabsorption
Thiazides cause sodium and water loss; the kidney compensates by reabsorbing more sodium — and lithium, which mimics sodium — raising lithium levels to potentially toxic concentrations.
A patient taking digoxin begins amiodarone therapy. What adjustment is typically needed?
Answer: Decrease the digoxin dose by approximately 50%
Amiodarone inhibits P-glycoprotein and CYP3A4/CYP2D6, reducing digoxin clearance. The digoxin dose should be reduced ~50% to avoid toxicity.
Taking an MAOI within 14 days of starting meperidine can cause which life-threatening reaction?
Answer: Serotonin syndrome / hyperpyrexic crisis
Meperidine inhibits serotonin reuptake; combined with MAOIs, this causes serotonin syndrome presenting as hyperpyrexia, rigidity, seizures, and cardiovascular instability.